Evidence map›Paper›PMID 27981043›Full record

ArticleJournal of diabetes and metabolic disorders2016

Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment.

Sabina Paglialunga, Angelica Guerrero, Julie M Roessig, Paul Rubin, Clayton A Dehn

Registry-linked trialOpen access · hybridAbstract readEditorial
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05031429 (Time Limited Eating in New-Onset Type 1 Diabetes), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05031429 nacompletednot on this mapstarted 2022, after this paper: background citation

Time Limited Eating in New-Onset Type 1 Diabetes: Feasibility, Acceptability, and Effect on β-cell Function

TypeinterventionalSponsorChildren's Hospital Los AngelesRan2022 to 2023Enrolled12ConditionsType 1 DiabetesArmsTime Limited Eating
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Glucolipotoxicity and GLP-1 secretion.BMJ open diabetes research & care · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sabina PaglialungaCelerion, 2420 W Baseline Road, Tempe, AZ 85283 USA.
Angelica GuerreroCelerion, 2420 W Baseline Road, Tempe, AZ 85283 USA ; Current Address: Clinical Trials of Texas, San Antonio, TX USA.
Julie M RoessigXOMA Corporation, Berkeley, CA USA.
Paul RubinXOMA Corporation, Berkeley, CA USA.
Clayton A DehnCelerion, 2420 W Baseline Road, Tempe, AZ 85283 USA ; Current Address: Umbrella Corporation, San Antonio, TX USA.
Celerion (United States) · USXOMA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a measure of insulin sensitivity, the mixed meal tolerance test (MMTT) is a simple technique that can provide robust results. The assay consists of examining plasma glucose, insulin and C-peptide prior to and following the consumption of a test meal. While this procedure has been used in clinical research for several years, there is no set standard protocol, and only until recently has the reliability of this assay been thoroughly evaluated in prediabetes and type 2 diabetes subjects. Interestingly, the results from this recent study demonstrated stronger MMTT reliability for the prediabetes and diabetes cohorts compared to obese controls. This finding suggests that the obese control group may have more inherent variability in glucose response during a meal challenge likely due to compensatory influences typically observed in non-diabetic insulin-resistant subjects. Furthermore, this study raises the question whether the MMTT assay is reliable in a non-obese cohort. Therefore, to promote the standardization of this technique and contribute to the band of insulin sensitive populations, we employed the same methodology and test meal as the reference study to evaluate the MMTT reliability in healthy and overweight men. Indeed, the interclass coefficient revealed high glucose response repeatability during the MMTT in insulin-sensitive men. Overall, the MMTT is a reliable test across a range of insulin sensitivity including healthy men. However, we propose further investigation may be required to fully define the utility of this methodology in obese non-diabetic insulin-resistant populations.

Indexed as

MMTTPostprandial glucoseReliability

Identifiers

PMID27981043
PMCPMC5142406
OpenAlexW2560197026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.